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Galectin-3 Regulates Intracellular Trafficking
of EGFR through Alix and Promotes Keratinocyte
Migration
Wei Liu1, Daniel K. Hsu1,2, Huan-Yuan Chen1,2, Ri-Yao Yang1, Kermit L. Carraway 3rd2,
Roslyn R. Isseroff1,3 and Fu-Tong Liu1,4
The EGFR-mediated signaling pathways are important in a variety of cellular processes, including cell
migration and wound re-epithelialization. Intracellular trafficking of EGFR is critical for maintaining EGFR
surface expression. Galectin-3, a member of an animal lectin family, has been implicated in a number of
physiological and pathological processes. Through studies of galectin-3-deficient mice and cells isolated from
these mice, we demonstrated that the absence of galectin-3 impairs keratinocyte migration and skin wound
re-epithelialization. We have linked this pro-migratory function to a crucial role of cytosolic galectin-3 in
controlling intracellular trafficking and cell surface expression of EGFR after EGF stimulation. Without
galectin-3, the surface levels of EGFR are markedly reduced, and the receptor accumulates diffusely in the
cytoplasm. This is associated with reduced rates of both endocytosis and recycling of the receptor. We have
provided evidence that this previously unreported function of galectin-3 may be mediated through
interaction with its binding partner Alix, which is a protein component of the ESCRT (endosomal sorting
complex required for transport) machinery. Our results suggest that galectin-3 is potentially a critical
regulator of a number of important cellular responses through its intracellular control of trafficking of cell
surface receptors.
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INTRODUCTION
Galectins are a family of animal lectins containing conserved
protein domains and preferential b-galactoside-binding ac-
tivity (Cummings and Liu, 2009). Fifteen members have been
identified in mammals and described to participate in various
physiological and pathological processes, including the
immune response (Liu, 2005), inflammation (Rabinovich
and Toscano, 2009; Liu and Rabinovich, 2010), as well as
cancer progression and metastasis (Liu and Rabinovich,
2005), by modulating cell proliferation (Scott and Weinberg,
2004), cell adhesion (Taylor and Drickamer, 2007), and
apoptosis (Nakahara et al., 2005; Hsu et al., 2006).
Galectin-3 is a chimeric protein and is one of the
most extensively studied members. Its C-terminal region
constitutes the carbohydrate-binding domain, and N-terminal
region contains tandem repeats that are rich in proline and
glycine residues. Similar to other galectins, galectin-3 does
not have a classical signal sequence, but can be released into
the extracellular space through a nonclassical secretory
pathway (Hughes, 1999). Extracellular and intracellular
functions have been demonstrated for this protein
(Dumic et al., 2006). Galectin-3 can interact extracellularly
with cell surface glycoproteins and influence a variety of
cellular responses, as well as modulate the properties
of cell surface receptors (Demetriou et al., 2001; Partridge
et al., 2004). Intracellularly, galectin-3 is anti-apoptotic
in the human Jurkat T-cell line (Yang et al., 1996) and a
variety of normal and tumor cells (reviewed in Nakahara
et al., 2005). Intracellular galectin-3 also contributes to
apical non-raft domain protein sorting (Delacour et al.,
2006), glycoprotein clustering (Delacour et al., 2007), and
apical membrane organization (Delacour et al., 2008).
Studies on galectin-3-deficient (gal3/) mice have
demonstrated that galectin-3 regulates mast cell activation
(Chen et al., 2006), macrophage phagocytosis (Sano et al.,
2003), alternative macrophage activation (MacKinnon
et al., 2008), and TCR-mediated CD4þ T-cell activation
(Chen et al., 2009). Galectin-3 has also been demon-
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strated to have a role in pre-mRNA splicing (Dagher et al.,
1995).
Diverse functions of galectin-3 suggest that it may have a
role in global processes, such as wound healing. Keratinocyte
migration is a crucial step required for skin wound re-
epithelialization (Santoro and Gaudino, 2005), and the EGF-
stimulated EGFR/extracellular signal–regulated kinase (ERK)
signaling pathway has a central role in this process
(McCawley et al., 1998; Shirakata et al., 2005). Upon EGF
stimulation, EGFR is phosphorylated, which is followed by
activation of the downstream Src/Ras/ERK signaling pathway.
The receptor is ubiquitinated and downregulated through
either clathrin-mediated endocytosis (Haigler et al., 1979) or
caveolae-mediated pinocytosis (Sigismund et al., 2005). After
endocytosis, ubiquitinated EGFR is transported to early
endosomes that can undergo membrane invagination to form
multivesicular bodies (MVBs). These intracellular structures
are crucial for receptor downregulation (von Zastrow and
Sorkin, 2007; Zwang and Yarden, 2009). EGFR can be sorted
to different compartments inside the cell through MVBs
(Katzmann et al., 2002), recycled to the plasma membrane,
or degraded when the MVBs are fused with lysosomes.
Importantly, an identified intracellular binding partner of
galectin-3 is Alix (Chen et al., 2009), a protein component of
the ESCRT (endosomal sorting complex required for transport)
machinery (Katoh et al., 2003). Alix has been demonstrated
to attenuate EGFR endocytosis (Schmidt et al., 2004) and
has been shown to regulate membrane invagination in
early endosomes and formation of MVBs in vitro (Falguieres
et al., 2008).
Galectin-3 has been reported to influence cell motility in
different cell types, but its effect can be either positive (Kim
et al., 2010) or negative (Debray et al., 2004). In gastric
cancer cells, silencing galectin-3 expression decreased cell
motility (Kim et al., 2010); however, stable transfection of a
human glioblastoma cell line with a galectin-3 antisense
plasmid resulted in increased cell motility (Debray et al.,
2004). Exogenous galectin-3 has been reported to promote
human keratinocyte migration at low concentrations through
laminin-332 binding, but it inhibits migration at high
concentrations (Kariya et al., 2010). Defective corneal wound
re-epithelialization was observed in gal3/ mice (Cao et al.,
2002), but the mechanism by which endogenous galectin-3
contributes to this process is unknown.
We used gal3/ mice and keratinocytes isolated from
these mice to investigate the role of endogenous galectin-3 in
skin wound re-epithelialization and keratinocyte migration
and found that keratinocyte migration is impaired in the
absence of galectin-3. Moreover, galectin-3 functions by
regulating intracellular trafficking of EGFR. We provide
evidence that galectin-3 does so by interacting with Alix
and modulating the association of Alix with EGFR.
RESULTS
Gal3/ keratinocytes are defective in migration both in vitro
and in vivo
To determine the effect of endogenous galectin-3 on keratino-
cyte migration, we compared the migratory speeds of gal3þ /þ
and gal3/ mouse keratinocytes by using a single-cell
migration assay. The migratory rate of the gal3/ cells was
significantly lower than that of the gal3þ /þ counterparts
(Figure 1a). We also examined keratinocyte migration by
scratch assay with confluent keratinocyte monolayers. The
scratched areas in gal3þ /þ monolayers were repaired by
58±4.1% within 48hours, whereas those in gal3/ cultures
were repaired by 36±2.85% (P¼ 0.006) in the same period
(Figure 1b and c).
The migratory defect in gal3/ keratinocytes in vitro
suggested that gal3/ mice might exhibit impaired skin
wound healing. We performed a dorsal wound assay. To
minimize the contribution of dermal contraction, wound
healing at an early time point after wounding (day 2) was
compared, and the areas of epithelial tongues were mea-
sured. Gal3/ mice demonstrated significantly impaired re-
epithelialization compared with gal3þ /þ mice (Figure 1e), as
determined by the outgrowth of epithelial tongues of the
regenerating epidermis (Figure 1d). No difference was found
in the epidermal thicknesses between the two genotypes of
mice (data not shown).
We addressed whether extracellular galectin-3 has a role
in keratinocyte migration. First, no surface galectin-3 was
detected by immunofluorescence microscopy. Galectin-3 is
positively stained only when another intracellular cytoskele-
ton protein tubulin is also positive resulting from permeabi-
lization and loss of cell membrane integrity (Supplementary
Figure S1a online). Galectin-3 was also not detected on the
cell surface of gal3þ /þ keratinocytes by flow cytometry
(Supplementary Figure S1b and c online). We tested the effect
of recombinant galectin-3 on keratinocyte migration. In both
mouse and human keratinocytes, recombinant galectin-3
stimulated cell migration in a lactose-inhibitable manner
(Supplementary Figure S2a and b online). However, lactose
at concentrations that effectively inhibit the pro-migratory
effect of exogenous galectin-3 did not influence the intrinsic
ability of keratinocytes to migrate (Supplementary Figure S2c
online). This suggests that higher motility of gal3þ /þ
keratinocytes over gal3/ cells is not due to secreted
galectin-3 acting in an autocrine or paracrine manner.
In addition, galectin-3 was found to translocate to the
leading edge of keratinocytes before active cell migration
30minutes after an in vitro scratch wound, and was
colocalized with phosphotyrosine (Supplementary Figure S3a
and b online), suggesting that galectin-3 may be involved in
the signal transduction process before active migration.
Gal3/ keratinocytes exhibit significantly reduced surface
EGFR expression and downstream ERK signaling response
As the EGFR/ERK signaling pathway has a central role in
keratinocyte migration (Fang et al., 1999), we compared
phosphorylation of EGFR and ERK between gal3þ /þ and
gal3/ mouse keratinocytes stimulated with mouse EGF at
50 ngml1. Figure 2a and b shows that at 5 and 10minutes
after EGF stimulation, gal3þ /þ keratinocytes exhibited higher
phosphorylation of both EGFR (at tyrosine 1068 residue) and
ERK compared with gal3/ keratinocytes. We demonstrated
that the migratory defects in gal3/ keratinocytes were due
www.jidonline.org 2829
W Liu et al.
Galectin-3 Regulates Intracellular Trafficking of EGFR
to a reduced EGFR/ERK response by using an EGFR tyrosine
kinase–specific inhibitor PD15035 in a single-cell migration
assay. The migratory speed of gal3þ /þ keratinocytes was
significantly reduced by PD15035 (Figure 2c), but gal3/
keratinocytes were unaffected. In the presence of this
inhibitor, the migratory speeds of two genotypes of cells
were equalized. The expression of galectin-3 did not
change after PD15035 treatment (data not shown). These
data suggest that galectin-3 modulates keratinocyte migra-
tion through its influence on EGFR signal transduction in
response to EGF.
We compared the cell surface EGFR expression between
gal3þ /þ and gal3/ mouse keratinocytes by flow cytometry
(Figure 2e). The mean fluorescence intensity of EGFR in gal3þ /
þ mouse keratinocytes was significantly higher than that in
gal3/ cells (5.5±0.9 vs. 0.8±0.04, Po0.05). Remarkably,
although immunofluorescence staining revealed that EGFR was
distributed on the plasma membrane in gal3þ /þ cells, as
expected, it was found to be largely localized in the cytoplasm
in gal3/ keratinocytes. To test whether exogenously added
galectin-3 can correct the aberrant distribution of EGFR in
gal3/ keratinocytes, we added recombinant galectin-3 to
gal3/ keratinocytes. We found that this did not alter the
cytoplasmic accumulation of EGFR (Figure 2e).
This differential localization was also observed in wounded
skin sections (Figure 2f). It is known that after skin wounding
EGFR is upregulated in periwounded epidermis. In gal3þ /þ
mice, EGFR was localized at the basolateral domain in regions
of cell-to-cell contact in the epidermis, 4 days after
full-thickness skin wounding. In significant contrast, EGFR
accumulated in the cytoplasm of keratinocytes and was
not detectable on the plasma membrane in gal3/ mice
(Figure 2f).
Regulation of EGFR surface expression by galectin-3 is
dependent on EGF stimulation
We then tested the consequence of EGF stimulation based on
the marked differences we observed in the surface expression
patterns of EGFR in gal3þ /þ and gal3/ mouse keratino-
cytes. After growth factor deprivation, EGFR was localized on
the plasma membrane in both genotypes (Figure 3a, 0 hours).
At 6 hours after EGF stimulation, the receptor was present on
the plasma membrane in gal3þ /þ keratinocytes, but was
accumulated in the cytoplasm of gal3/ cells (Figure 3a,
6 hours). Expression levels of EGFR were comparable
between gal3þ /þ and gal/ keratinocytes in immunoblots
after growth factor deprivation (Figure 3b, lanes 3 and 4).
However, after culturing in medium containing growth
factor, the levels of the receptor in gal3/ keratinocytes
were higher compared with those in gal3þ /þ counterparts
(Figure 3b, lanes 1 and 2).
Intracellular trafficking of EGFR is impaired in gal3/
keratinocytes
Different pathways are engaged for endocytosis and recycling
of EGFR in response to different concentrations of its ligand.
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Figure 1. Galectin-3-deficient (gal3/) keratinocytes exhibit defective migration in vitro and in vivo. (a) Single-cell migration speeds were compared between
gal3þ /þ and gal3/ keratinocytes. The speeds are presented as averages during a 1-h period. Data shown are the mean speeds±SEM of four independent
experiments. *P¼ 0.025. (b, c) Gal3þ /þ and gal3/ keratinocyte monolayers were scratched, and images at time 0, and 6, 24, and 48hours after scratch are
presented. Representative images from nine nonoverlapping regions from one of three independent experiments are shown. (c) Comparison of gal3þ /þ and
gal3/ wounds as a percentage of area at time t relative to time 0. Values are mean percentages±SEM, n¼ 9. *P¼ 0.006. Scale bar¼20 mm. (d) Representative
images from gal3þ /þ and gal3/ tissues of partially healed wounds and periwounded regions are shown. Arrowheads point to outlines of advancing epithelial
tongues at one edge of the wound. Bar¼ 100mm. (e) Areas of re-epithelialized regions in healing wounds from gal3þ /þ and gal3/ mice, as shown in d, were
digitally measured from micrographs. Data represent the means±SEM from two wounds per mouse and six mice per genotype. *P¼ 0.017.
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Under physiological conditions (EGF 1–2 ngml1), EGFR is
endocytosed mainly through a clathrin-mediated pathway.
However, under pathological conditions such as during a
wound healing process, when the concentrations of growth
factors increase significantly in the affected area, caveolae-
mediated endocytosis is also involved. Therefore, in this
study, various concentrations of EGF stimulation were used.
The observed differences in EGF-induced redistribution of the
EGFR in gal3þ /þ and gal3/ keratinocytes suggested the
presence of a defect in receptor intracellular trafficking
in gal3/ keratinocytes. We observed that the rate of
EGF-induced endocytosis of EGFR was lower in gal3/
keratinocytes relative to gal3þ /þ cells (Figure 4a and b). At
low concentrations of EGF (1–2 ngml1), the rate of EGFR
endocytosis in gal3/ keratinocytes was lower than that in
gal3þ /þ cells (Figure 4a), and at high concentrations of EGF
(40–100 ngml1) EGFR endocytosis in gal3/ keratinocytes
was undetectable during the time frame when the receptor
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*P¼0.0004. (d) Cell surface expression of EGFR was measured by flow cytometry and is presented as MFI (mean fluorescence intensity compared with control
rat-IgG antibody, red). P¼ 0.0006. The insets (dot plots) show that 98.6% gal3þ /þ and 98.3% gal3/ keratinocytes were gated for EGFR expression analysis. (e)
EGFR was visualized with rabbit anti-EGFR and Alexa 488–conjugated secondary antibody (green). Bar¼20 mm. (f) Gal3þ /þ and / mice skin wound samples
were fixed at day 4, and sections were prepared for immunofluorescence detection of EGFR. Bar¼ 20 mm.
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clearly underwent endocytosis in gal3þ /þ cells (Figure 4b).
EGFR recycling was also deficient in gal3/ keratinocytes.
Following stimulation with low concentrations of EGF, EGFR
recycled to the cell surface shortly after its internalization in
both genotypes, but at a lower rate in gal3/ keratinocytes
(Figure 4c). At high concentrations of EGF stimulation, EGFR
was able to recycle to the cell surface in gal3þ /þ cells within
30minutes, whereas no EGFR recycling was detected in
gal3/ keratinocytes within this period (Figure 4d). To
monitor endocytosis and recycling in gal3/ keratinocytes
treated with high concentrations of EGF for a longer period,
we cultured the cells in the presence of 40 ngml1 of EGF for
6 hours, a condition under which EGFR is known to
accumulate in the cytosol in gal3/ keratinocytes. We then
cultured the cells in the presence of a protein synthesis
inhibitor, cycloheximide, and monitored recycling of the
receptor. We did not find significant recycling during the
6 hours of incubation (Figure 4e).
Galectin-3 regulates intracellular trafficking of EGFR through
Alix
By yeast two-hybrid screening of a complementary DNA
library generated from the human Jurkat T-cell line, we
previously identified Alix as a binding partner of galectin-3
(Chen et al., 2009). Alix is known to attenuate EGFR
endocytosis (Schmidt et al., 2004) and regulate membrane
invagination in early endosomes and formation of MVBs
in vitro (Falguieres et al., 2008). Here we demonstrate that
after chemical crosslinking with disuccinimidyl suberate,
galectin-3 could be co-immunoprecipitated with Alix from
cultured keratinocytes without EGF stimulation (time 0), and
there was increased interaction between galectin-3 and Alix
30minutes after EGF stimulation (Figure 5a). In addition,
galectin-3 was colocalized with Alix at 30minutes after
scratch in neonatal human keratinocyte monolayers at the
leading edge of the migrating cells (Figure 5c).
EGFR is known to be indirectly associated with Alix
(Schmidt et al., 2004). To address whether intracellular
galectin-3 affects the association between EGFR and Alix, we
compared the amounts of EGFR co-immunoprecipitated with
Alix in gal3þ /þ and gal3/ keratinocytes that were treated
with a membrane-permeable chemical crosslinker (Figure
5b). EGFR released from the plasma membrane during cell
lysis can potentially bind to galectin-3 through lectin–carbo-
hydrate interactions and appear as being associated with
Alix, if the galectin-3 protein is complexed with Alix and its
carbohydrate-binding site is unoccupied. To exclude this
possibility, we included 5mM lactose in the lysis buffer to
block galectin-3 carbohydrate binding. In gal3þ /þ keratino-
cytes, EGFR was not associated with Alix at time 0, but
increased association was noted 10minutes after EGF
stimulation. In contrast, there was a significant amount of
EGFR associated with Alix at time 0 in gal3/ keratinocytes,
but the association was reduced 10minutes after EGF
stimulation, and the amount of EGFR associated with Alix
was significantly lower compared with that in gal3þ /þ cells
(Figure 5b). The results suggest that galectin-3 is critical for
modulating Alix/EGFR association after EGF stimulation by
binding to Alix.
DISCUSSION
We have established that endogenous galectin-3 positively
regulates keratinocyte migration and skin wound re-epithelia-
lization in a mouse model. This effect is mediated by the
regulation of cell surface EGFR expression by cytosolic
galectin-3, and it does so by modulating intracellular
trafficking of the receptor, including endocytosis and recy-
cling. We also show here that intracellular galectin-3 functions
by modulating the properties of its binding partner Alix.
The most striking findings in our study are marked over-
expression and redistribution of the EGFR protein in cultured
gal3/ keratinocytes, and during skin wound healing in
gal3/ mice (Figure 2e and f). This is induced by ligand
restimulation. Under normal cell culture conditions or during
skin wounding, where keratinocytes are exposed to various
growth factors, including EGF, galectin-3 is critical for
intracellular EGFR trafficking and surface expression. However,
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when keratinocytes are cultured in growth factor–deficient
medium (although ligands of EGFR secreted by keratinocytes
through autocrine mechanism may still be present (Kansra
et al., 2004)) or under low concentrations of EGF stimulation,
galectin-3 does not significantly affect the cell surface level of
EGFR. Therefore, the presence of abundant growth factor and
growth factor–induced receptor internalization are the pre-
requisites for the regulation of EGFR trafficking and surface
expression by galectin-3.
Consistent with this, the defects in EGFR endocytosis and
recycling are more prominent at high concentrations of EGF
stimulation in gal3/ keratinocytes. We conclude that
although the absence of galectin-3 results in inefficiency in
both endocytosis and recycling of EGFR under conditions of
abundant growth factor, the defect in the latter is the primary
cause of reduced surface expression of EGFR and cytoplasmic
accumulation of this protein under these conditions in
gal3/ keratinocytes (i.e., the receptor is highly ineffective
in recycling to the cell surface once internalized).
We previously identified Alix as a binding partner of
galectin-3. We also observed that galectin-3 is colocalized
with Alix in both the leading edge of migrating cells and
cytoplasm (Figure 5c). Moreover, Alix is known to indirectly
associate with EGFR and suppress its endocytosis (Schmidt
et al., 2004), and we observed that galectin-3 regulates the
association of Alix and EGFR after EGF stimulation, as this
association is diminished in the absence of galectin-3 (Figure
5b). Alix has been identified as a component of ESCRT
protein complex and is involved in MVB formation. Through
binding to Alix, galectin-3 may have a broader impact on
membrane protein intracellular trafficking in general.
Galectin-3 is known to bind to EGFR through lectin–car-
bohydrate interactions (Dennis et al., 2002; Lau et al., 2007;
Ramasamy et al., 2007). Partridge et al. (2004) found that
highly branched glycans on EGFR, resulting from modifica-
tion by 1,6 N-acetylglucosaminyltransferase V (Mgat5/GnT-
Va), are recognized by galectin-3. Furthermore, they found in
Mgat5/ cells containing limited glycan branching that (1)
cell surface expression levels of both EGFR and galectin-3
were constitutively reduced; (2) the levels of galectin-3
associated with EGFR were reduced; and (3) EGFR endocy-
tosis was increased in the absence of ligand stimulation, as
detected by the amount of EGFR colocalized with an early
endosome marker, EEA1 (early endosome antigen 1). In
addition, removal of galectin-3 from the cell surface of wild-
type cells by lactose resulted in a phenotype similar to that of
Mgat5/ cells. Thus, they proposed a model in which
galectin-3 interacts with Mgat5-modified EGFR on the plasma
membrane to form lattices, thereby retarding receptor
endocytosis. Although this model can account for the
reduced surface expression of EGFR in gal3/ keratinocytes,
it does not fully explain our findings. We observed that the
ligand-induced rate of EGFR endocytosis was actually lower
in gal3/ mouse keratinocytes compared with the gal3þ /þ
counterparts (Figure 4a and b), in contrast to higher rates of
endocytosis, as the galectin-3 lattice model would predict. It
should be mentioned that another study found that knock-
down of GnT-Va (or Mgat5a) by small interfering RNA
treatment (which would reduce branching of EGFR glycans)
in MDA-MB231 cells resulted in lower EGF-induced rates of
EGFR endocytosis. However, extracellular galectin-3 did not
appear to have a role in receptor endocytosis resulting from
knocking down the enzyme (Guo et al., 2009).
We were not able to detect galectin-3 on the cell surface
of primary human keratinocytes by immunofluorescence
microscopy. Galectin-3 is positively stained only when
another intracellular cytoskeleton protein tubulin is also
positive, upon loss of cell membrane integrity by permeabi-
lization (Supplementary Figure S1 online). It should also be
mentioned that, although we observed the ability of
recombinant galectin-3 to stimulate keratinocyte migration
in a lactose-inhibitable manner, lactose at concentrations that
effectively inhibit the pro-migratory effect of exogenous
galectin-3 did not inhibit the intrinsic ability of keratinocytes
to migrate (Supplementary Figure S2a and b online). This
suggests that higher motility of gal3þ /þ keratinocytes over
gal3/ cells is not due to the presence of secreted galectin-3
acting in an autocrine or paracrine manner.
Galectin-3 has been reported to function in trans-Golgi
network vesicles and to regulate sorting of non-raft proteins to
the apical domain in MDCK cells (Delacour et al., 2006).
When galectin-3 is downregulated by small interfering RNA,
these proteins were found to be missorted to the basolateral
domain. However, EGFR is not an apical protein, but is
normally located in the basolateral domain in keratinocytes
(Fang et al., 1999), and it has also been shown to be present
in lipid rafts (Yamabhai and Anderson, 2002). Gal3/
keratinocytes showed no defect in the transport of EGFR to
the plasma membrane, but only under growth factor
stimulation or in vivo conditions of wound repair was EGFR
found to be accumulated in the cytoplasm, rather than
missorted to different domains of the plasma membrane.
Importantly, we were unable to demonstrate EGFR and
endogenous galectin-3 interaction by chemical crosslinking.
Cao et al. (2002) found that gal3/mice were defective in
cornea wound healing, and recombinant galectin-3 could
promote wound re-epithelialization only in gal3þ /þ mice
and not in gal3/ mice. This intriguing finding can be
explained by our discovery of the intracellular function of
galectin-3 in regulating EGFR trafficking. In gal3þ /þ mice,
where EGFR intracellular trafficking pathways are intact,
exogenously added galectin-3 can engage the receptor and
promote cell migration. However, in the absence of
endogenous galectin-3, EGFR intracellular trafficking is
defective and, as a consequence, the cell surface levels of
EGFR are reduced and exogenous galectin-3 is not able to
promote cell migration. Indeed, we showed that exogenously
added galectin-3 did not change the cytoplasmic distribution
of EGFR in gal3/ cells (Figure 2e).
A large number of extracellular functions of galectin-3
have been described, which involve its binding to cell
surface glycoproteins (reviewed in Ochieng et al., 2004). Our
studies revealed a previously unreported intracellular func-
tion of this protein in the regulation of EGFR expression.
EGFR is well established as a master regulator of cell survival,
cell cycle progression, and neoplastic transformation and is
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implicated in a number of pathological conditions, including
cancers (Hynes and Lane, 2005). Thus, galectin-3 may have
an important role in these processes through regulation of this
receptor, and the potential exists for galectin-3 to be
considered as a therapeutic target in EGFR-dependent
pathologies. Our studies have uncovered a previously
unreported paradigm for intracellular regulation of multiple
cellular processes by galectin-3. This has a significant impact
on our understanding of the roles of intracellular galectins.
Finally, our studies also suggest a role for galectin-3 in skin
wound re-epithelialization, and this information may be
exploited for the development of a previously unreported
approach for treatment of chronic skin wounds.
MATERIALS AND METHODS
Mice
Gal3þ /þ and gal3/ C57BL6 mice were generated as described
previously (Hsu et al., 2000) and backcrossed to C57BL/6 for over
nine generations (Sano et al., 2003). All animal experiments were
approved by the University of California Davis Institutional Animal
Care and Use Committee and followed the guidelines of the Animal
Welfare Act and the Health Research Extension Act. Experiments
using human tissues were approved by the University of California
Davis Institutional Review Board.
Human primary keratinocyte culture and mouse primary
keratinocyte culture
Human keratinocytes were isolated from neonatal foreskins as
described (Isseroff et al., 1987) and cultured using a modified
method of Rheinwatd and Green (1975). Mouse epidermal keratino-
cytes were isolated from the epidermis of the newborn pups from
galectin-3 heterozygous breeders as described (Isseroff et al., 1985).
Purities were determined to be 99–100%. Human keratinocytes were
cultured with Epilife basal medium with the addition of 0.06mM
CaCl2 and 1% HKGS (human keratinocyte growth supplement) all
from Invitrogen (Carlsbad, CA). HKGS contains 0.2 ngml1 human
EGF, 5mgml1 insulin, 5mgml1 transferrin, 0.18mgml1 hydro-
cortisone, and 0.2% bovine pituitary extract. All human tissue studies
were approved by the institutional review board at the University of
California Davis, and conducted according to the Declaration of
Helsinki Principles, with written consent from all participants.
The medium used for culturing mouse keratinocytes contained
20ng mouse EGF, 10ngml1 cholera toxin, and 0.5% fetal bovine
serum, in addition to 1% HKGS, and the calcium concentration was
reduced to 0.02mM. In some experiments, growth factor–free basal
Epilife medium containing 0.02mM CaCl2 and 10ngml
1 cholera
toxin was used.
Single-cell migration
Single-cell migration experiments were performed as described (Chen
et al., 2002). Mouse keratinocytes were plated on glass coated with
60mgml1 collagen I (Cohesion Technologies, Palo Alto, CA) for
3hours. Slides were placed on a heated metal plate with negative
feedback temperature control system set at 37 1C. Time-lapse images
of the cell migration were captured every 10minutes for 1 hour.
‘‘Speed’’ is the average speed in mm per minute that the cells travel in a
1-hour period. In some experiments, gal3þ /þ and gal3/ keratino-
cytes were treated with 200nM PD15035 (in 0.05% DMSO) or with
0.05%DMSO control. To exclude the competing effects by the growth
factors in the medium, for experiments involving recombinant
galectin-3, gal3þ /þ mouse keratinocytes or human keratinocytes
were starved and then incubated in the presence of recombinant
galectin-3 (1mgml1), galectin-3 plus 25mM lactose or sucrose, or
25mM lactose or sucrose in growth factor–deficient medium. Cells
were cultured in an environmental chamber monitored under
microscopy with the temperature maintained at 37 1C and 5% CO2.
Scratch assay
Scratch assay was performed as described (Haas et al., 1990). Cells
were pretreated with 5 mgml1 mitomycin C for 1 hour. A sterile
200ml pipette tip was used to scratch a 1-mm-wide cell-free zone on
the monolayer. After removing the cell debris (time 0), nine
demarcated areas of the wound in each treatment were photo-
graphed under an inverted Nikon Diaphot (Melville, NY) micro-
scope at  20 magnification. The same areas were photographed at
various times after wounding for 48 hours.
Skin wounding experiment
Age- (8–12 weeks) and sex-matched gal3þ /þ and gal3/ C57BL/6
mice were anesthetized with 90mg kg1 ketamine/10mg kg1
xylazine intraperitoneally i.p. After hair removal and sterilization,
full-thickness wounds 3mm in diameter were made. Skin wound
samples were collected at day 2 for skin wound re-epithelialization
comparison, and day 4 for immunohistochemical staining of EGFR.
Re-epithelialized areas of the wound were measured as we have
previously described (Sivamani et al., 2009).
Immunofluorescence staining
A total of 3 104 neonatal human keratinocytes were cultured on
collagen I–coated glass coverslips. After fixation, cells were either
permeabilized with 0.1% Triton X-100/phosphate-buffered saline
(PBS) or not permeabilized, and standard immunofluore-
scence techniques were used to detect galectin-3 and tubulin. For
gal3þ /þ and gal3/ mouse keratinocytes, cells were stained with
rabbit anti-EGFR antibody (Cell Signaling, Danvers, MA) or rat anti-
mouse EGFR antibody (R&D Systems, Minneapolis, MN). Rabbit
anti-Alix sera were generated and described previously (Chen et al.,
2009), and further purified using Protein A–conjugated agarose
beads (Thermo Scientific, Rockford, IL). Rabbit IgG, rat IgG1, rat
IgG2a, mouse IgG1, and mouse IgG2b were used as isotype controls
(eBioscience, San Diego, CA). The concentration of all the primary
antibodies is 5mgml1.
Flow cytometry
Mouse keratinocytes were freshly isolated as described above. Cells
were blocked with 10% goat serum in PBS without fixation, and then
incubated with rat anti-mouse EGFR antibody (R&D Systems),
followed by Alexa 488–conjugated goat anti-rat antibody (Invitro-
gen). Cell surface EGFR expression was detected by flow cytometry
(Epics XL, Beckman-Coulter, Miami, FL).
Detection of galectin-3 on the cell surface was also accomplished
by flow cytometry. Cells were grown to 80% confluence and then,
after washing with 1 PBS, detached with Cellstripper for
30minutes at 37 1C. Detached cells were resuspended with PBS
on ice. After blocking with 10% BSA/PBS, cells were incubated
with 5mgml1 biotinylated rabbit anti-rat galectin-3 antibody or
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biotinylated rabbit IgG, and, after washing with 1% BSA/1 PBS,
then incubated with 5mgml1 Alexa 488–conjugated streptavidin.
Propidium iodide (1 mgml1) was used to exclude dead cells.
Cell lysate and western blot
The whole-cell lysates were prepared as previously described (Pullar
et al., 2006). The standard Tris-glycine-based western blotting
protocol was used for detection of EGFR and phospho-ERK.
Crosslinking and immunoprecipitation
Mouse keratinocytes were grown to 80% confluence. After starva-
tion for 16 hours, cells were stimulated with 50 ngml1 EGF for
30minutes, and crosslinked with disuccinimidyl suberate (5mM
(final), Thermo Scientific, Pittsburg, PA). Cells were then lysed in
buffer containing 5mM lactose. A measure of 100 mg proteins was
immunoabsorbed with 10 ml protein G–conjugated agarose beads
(from Thermo Scientific) and 5 mg mouse anti-Alix (AbD Serotec,
Raleigh, NC) or control mouse IgG1 antibody at 4 1C overnight. The
samples were centrifuged at 5,000 g for 1minute, and the super-
natants were saved as the unbound samples. The agarose beads in
the pellets were washed five times with lysis buffer, and processed
for immunoblotting.
EGFR endocytosis and recycling
Rates of EGFR endocytosis were measured by a flow cytometry–-
based method (Sigismund et al., 2008; Roepstorff et al., 2009;
Gostring et al., 2010). Cells were deprived of growth factor for
4 hours and detached with Cellstripper (Thermo Scientific) at 37 1C
for 20minutes. Cell viability was typically 90%. Cells were
resuspended in medium containing mouse EGF at 37 1C for various
periods, and fixed with 3.7% formalin. Cells were stained with
antibody, and cell surface EGFR levels were calculated as the ratio of
mean fluorescence intensity of the sample/Rat IgG1.
EGFR recycling rates were measured by flow cytometry. Starved
cells were detached with Cellstripper, as described above, and
incubated with 2 ngml1 or 10ngml1 EGF at 4 1C for 1 hour,
followed by incubation at 37 1C for 15minutes. After removal of
bound EGF by mild acidic stripping (0.2M acetic acid, 0.5M NaCl, pH
4.0) for 1minute, cells were washed with PBS, resuspended in EGFR-
free medium, and re-incubated for various periods at 37 1C. Surface
EGFR levels were measured by flow cytometry as described above.
Statistical analysis
Nonpaired equal variance, two-tailed Student’s t-test was used in
this study, and P-values o0.05 were considered significant.
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